Faculty profile

Anne Gatignol

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Anne Gatignol

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
6 publications in the last five years, latest in 2024.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 11 research grants (11 CIHR), most recently in 2023.
Supervisor on 4 trainee awards (4 CIHR), most recently in 2010.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Hiv Lymphocytes Sirnas Adar1 Pkr Innate Immunity Sars-Cov-2 Rna Interference

Latest papers

[From viral disease gender to viral species subclassification: how to find our way around?].
Virologie (Montrouge, France) · 2024 · senior author
MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV.
Retrovirology · 2024 · senior author
Gene therapy to cure HIV infection.
Virologie (Montrouge, France) · 2023

All 36 publications

Latest funding

Development of RNA therapies against SARS-CoV-2, other coronaviruses and influenza viruses for pandemic preparedness
CIHR · 2023 · Nominated PI
$100,000
COVID-19 Variant Supplement - Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
CIHR · 2021 · Nominated PI
$50,000
Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
CIHR · 2020 · Nominated PI
$360,377

All 16 grants and awards

36 publications.

[From viral disease gender to viral species subclassification: how to find our way around?].

Tournier JN, Tordo N, Gilmer D, Gatignol A

Virologie (Montrouge, France)2024Senior author

DOI: 10.1684/vir.2024.1068 PMID: 39707591

MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV.

Alpuche-Lazcano SP, Scarborough RJ, Gatignol A

Retrovirology2024Senior author

DOI: 10.1186/s12977-024-00637-y PMID: 38424561

Gene therapy to cure HIV infection.

Goguen RP, Chen MJ, Dunkley ORS, Gatignol A, Scarborough RJ

Virologie (Montrouge, France)2023

DOI: 10.1684/vir.2023.1024 PMID: 37997882

[Gene therapy to cure HIV infection].

Goguen RP, Chen MJ, Dunkley ORS, Gatignol A, Scarborough RJ

Virologie (Montrouge, France)2023

DOI: 10.1684/vir.2023.1021 PMID: 37991319

The discovery and development of RNA-based therapies for treatment of HIV-1 infection.

Chen MJ, Gatignol A, Scarborough RJ

Expert opinion on drug discovery2023

DOI: 10.1080/17460441.2022.2117296 PMID: 36004505

[A year in Virologie: some viruses persist, others emerge].

Vitour D, Nisole S, Lévêque N, Saulnier A, Tordo N, Gatignol A, Gilmer D

Virologie (Montrouge, France)2022

DOI: 10.1684/vir.2022.0980 PMID: 36565257

Profound downregulation of neural transcription factor Npas4 and Nr4a family in fetal mice neurons infected with Zika virus.

Alpuche-Lazcano SP, Saliba J, Costa VV, Campolina-Silva GH, Marim FM, Ribeiro LS, Blank V, Mouland AJ, Teixeira MM, Gatignol A

PLoS neglected tropical diseases2021Senior author

DOI: 10.1371/journal.pntd.0009425 PMID: 34048439

Efficacy, accumulation, and transcriptional profile of anti-HIV shRNAs expressed from human U6, 7SK, and H1 promoters.

Goguen RP, Del Corpo O, Malard A, Daher A, Alpuche-Lazcano SP, Chen MJ, Scarborough RJ, Gatignol A

Molecular therapy. Nucleic acids2021Senior author

DOI: 10.1016/j.omtn.2020.12.022 PMID: 33614248

Cloning and Detection of Aptamer-Ribozyme Conjugations.

Goguen RP, Gatignol A, Scarborough RJ

Methods in molecular biology (Clifton, N.J.)2021

DOI: 10.1007/978-1-0716-0716-9_14 PMID: 32712924

[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].

Nisole S, Saulnier A, Gatignol A

Virologie (Montrouge, France)2020Senior author

DOI: 10.1684/vir.2020.0843 PMID: 32648548

Something wrong or missing on this profile? Suggest a correction

Anne Gatignol

Research

Latest papers

Latest funding

[From viral disease gender to viral species subclassification: how to find our way around?].

MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV.

Gene therapy to cure HIV infection.

[Gene therapy to cure HIV infection].

The discovery and development of RNA-based therapies for treatment of HIV-1 infection.

[A year in Virologie: some viruses persist, others emerge].

Profound downregulation of neural transcription factor Npas4 and Nr4a family in fetal mice neurons infected with Zika virus.

Efficacy, accumulation, and transcriptional profile of anti-HIV shRNAs expressed from human U6, 7SK, and H1 promoters.

Cloning and Detection of Aptamer-Ribozyme Conjugations.

[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].

Development of RNA therapies against SARS-CoV-2, other coronaviruses and influenza viruses for pandemic preparedness

COVID-19 Variant Supplement - Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)

Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)

Development of small RNAs for HIV-1 gene and drug therapy

HIV-induced modifications of the RNA interference pathway

Virus-cell interactions in the regulation of HIV translation

Virus-cell interactions in the regulation of HIV translation

The Canadian HIV Cure Enterprise (CanCURE)

Development of antisense-based small RNA agents targeting the GAG open reading frame of HIV-1 RNA for use in gene and drug therapy against HIV-1 infection.

Exploring interactions between HIV and the RNA interference pathway

Frequent collaborators

Hugo Soudeyns

Jean-Pierre Perreault

Volker Blank

Jean-Pierre Routy

Nathalie Grandvaux

Rongtuan Lin

Chen Liang

Anne Gatignol

Research

Latest papers

Latest funding

[From viral disease gender to viral species subclassification: how to find our way around?].

MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV.

Gene therapy to cure HIV infection.

[Gene therapy to cure HIV infection].

The discovery and development of RNA-based therapies for treatment of HIV-1 infection.

[A year in Virologie: some viruses persist, others emerge].

Profound downregulation of neural transcription factor Npas4 and Nr4a family in fetal mice neurons infected with Zika virus.

Efficacy, accumulation, and transcriptional profile of anti-HIV shRNAs expressed from human U6, 7SK, and H1 promoters.

Cloning and Detection of Aptamer-Ribozyme Conjugations.

[Severe acute respiratory syndrome coronavirus 2&#xa0;(SARS-CoV-2): Should we target the virus, the cell or the disease?].

Frequent collaborators

Hugo Soudeyns

Jean-Pierre Perreault

Volker Blank

Jean-Pierre Routy

Nathalie Grandvaux

Rongtuan Lin

Chen Liang

[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].